Secondary prevention of cerebral infarction with cilostazol - A multicenter, double-blind, placebo-controlled, long term, randomized study (Cilostazol Stroke Prevention Study, CSPS)

Journal of Stroke and Cerebrovascular Diseases

Volumn 9, Issue 2 SUPPL., 2000, Pages 374-375

  Gotoh, F ^a   Tohgi, H ^a   Hirai, S ^a   Terasi, A ^a   Fukuuchi, Y ^a   Ohtomo, E ^a   Shinohara, Y ^a   Itoh, E ^a   Matsuda, T ^a   Sawada, T ^a   Yamaguchi, T ^a   Nishimaru, Y ^a   Ohashi, Y ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CILOSTAZOL; TICLOPIDINE;

AGED; BRAIN INFARCTION; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SECONDARY PREVENTION; STROKE;

EID: 0033762182     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (6)

1. Mechanisms of antiplatelet agents and the prevention of stroke
2. Asia pacific consensus forum on stroke management
3. The Canadian American ticlopidine study (CATS) in thromboembolic stroke
4. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy-I Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
5. Design and organization of the Cilostazol Stroke Prevention Study
6. Effects of a selective inhibitor of cyclic AMP phosphodiesterase on the pial microcirculation in feline cerebral ischemia